Novartis Canada is pleased to announce that Fabhalta® (iptacopan capsules) is now available across Canada for adult patients ...

The Novartis logo is seen on a new cell and gene therapy factory in Stein, Switzerland. (File photo by Arnd Wiegmann/Reuters) Swiss pharmaceutical giant Novartis announced it will spend $23 ...

NEW YORK – Swiss pharmaceutical giant Novartis said it will invest US$23 billion (S$30.5 billion) in the US over the next five years to ensure its key drugs for Americans are made in the country ...

Richard Lafayette, MD, FACP, Stanford University Medical Center, explains the significance of this second approval in a month ...

[NEW YORK] Swiss pharmaceutical giant Novartis said it would invest US$23 billion in the US over the next five years to ensure its key drugs for Americans are made in the country, with the ...

Swiss drugmaker Novartis said today it plans to spend $23 billion to build and expand 10 facilities in the US, as it grapples with renewed threats of drug import duties from the Trump administration.

Swiss pharmaceutical giant Novartis announced Thursday that it plans to expand its manufacturing and research and development activities in the US with an investment of $23 billion over the next ...

Novartis plans to invest $23 billion over the next five years to expand its manufacturing and research in the U.S. The investment will cover more than 10 facilities, including seven new sites, and ...

During a median follow-up period of 12.3 years, 4399 cases of diabetic microvascular complications were recorded, including 2084 cases of nephropathy, 2401 cases of retinopathy, and 831 cases of ...

Novartis said it plans to invest $23 billion in the construction and expansion of U.S. facilities. The move comes after President Trump earlier this week threatened "major" tariffs on ...

Pharmaceutical company Novartis said it plans to expand U.S.-based manufacturing and research and development, with a total investment of $23 billion over the next five years. The company said it ...